BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9328447)

  • 21. Characterization of the human myeloid cell nuclear differentiation antigen: relationship to interferon-inducible proteins.
    Burrus GR; Briggs JA; Briggs RC
    J Cell Biochem; 1992 Feb; 48(2):190-202. PubMed ID: 1377701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP.
    Hanissian SH; Akbar U; Teng B; Janjetovic Z; Hoffmann A; Hitzler JK; Iscove N; Hamre K; Du X; Tong Y; Mukatira S; Robertson JH; Morris SW
    Oncogene; 2004 Apr; 23(20):3700-7. PubMed ID: 15116101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
    Bischof D; Pulford K; Mason DY; Morris SW
    Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
    Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
    Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
    Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
    Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of t(3;5) and NPM1/MLF1 rearrangement in an elderly patient with acute myeloid leukemia: clinical and laboratory study with review of the literature.
    Lim G; Choi JR; Kim MJ; Kim SY; Lee HJ; Suh JT; Yoon HJ; Lee J; Lee S; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Jun; 199(2):101-9. PubMed ID: 20471513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
    Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
    PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.
    Fornerod M; Boer J; van Baal S; Jaeglé M; von Lindern M; Murti KG; Davis D; Bonten J; Buijs A; Grosveld G
    Oncogene; 1995 May; 10(9):1739-48. PubMed ID: 7753551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation.
    Mason DY; Pulford KA; Bischof D; Kuefer MU; Butler LH; Lamant L; Delsol G; Morris SW
    Cancer Res; 1998 Mar; 58(5):1057-62. PubMed ID: 9500471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic organization, tissue expression, and cellular localization of AF3p21, a fusion partner of MLL in therapy-related leukemia.
    Hayakawa A; Matsuda Y; Daibata M; Nakamura H; Sano K
    Genes Chromosomes Cancer; 2001 Apr; 30(4):364-74. PubMed ID: 11241789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity.
    Kondo T; Minamino N; Nagamura-Inoue T; Matsumoto M; Taniguchi T; Tanaka N
    Oncogene; 1997 Sep; 15(11):1275-81. PubMed ID: 9315094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
    Lai F; Godley LA; Fernald AA; Orelli BJ; Pamintuan L; Zhao N; Le Beau MM
    Genomics; 2000 Nov; 70(1):123-30. PubMed ID: 11087669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
    Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
    Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.
    Mariano AR; Colombo E; Luzi L; Martinelli P; Volorio S; Bernard L; Meani N; Bergomas R; Alcalay M; Pelicci PG
    Oncogene; 2006 Jul; 25(31):4376-80. PubMed ID: 16501600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).
    Fujimoto J; Shiota M; Iwahara T; Seki N; Satoh H; Mori S; Yamamoto T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4181-6. PubMed ID: 8633037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region.
    Chan PK; Chan FY; Morris SW; Xie Z
    Nucleic Acids Res; 1997 Mar; 25(6):1225-32. PubMed ID: 9092633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.